Spyre Therapeutics, Inc. short interest in 2023
In 2023, Spyre Therapeutics, Inc.'s disclosed short interest ran from 0.98% of shares outstanding on 13 Jan 2023 to 1.52% on 31 Aug 2023, a change of +0.54 percentage points. The year's high was 1.55% on 15 Aug 2023 and its low 0.51% on 31 May 2023, averaging 0.99% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.47 days on 31 Aug 2023. Full history: Spyre Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.98% (13 Jan 2023)
- End of year
- 1.52% (31 Aug 2023)
- Change
- +0.54 pp
- High
- 1.55% (15 Aug 2023)
- Low
- 0.51% (31 May 2023)
- Average
- 0.99%
- Highest days to cover
- 6.47 (31 Aug 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.98% | 1.19 | |
| 31 Jan 2023 | 0.86% | 1.69 | |
| 15 Feb 2023 | 1.19% | 1.80 | |
| 28 Feb 2023 | 0.92% | 2.31 | |
| 31 Mar 2023 | 1.03% | 3.75 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 1.16% | 1.00 | |
| 28 Apr 2023 | 0.70% | 1.00 | results (8-K) |
| 15 May 2023 | 0.66% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2023 | 0.51% | 1.00 | |
| 15 Jun 2023 | 0.76% | 1.00 | |
| 15 Aug 2023 | 1.55% | 2.83 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.52% | 6.47 |
See also: Spyre Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.